Closed Loop Medicine

Single prescription drug plus digital therapy development platform

Closed Loop Medicine logo
21-100 employees
  • Healthcare
  • B2B
  • Manufacturing
  • Biology
  • MedTech
London, UK

Company mission

To improve patients’ lives by creating closed loop models of care.

Our take

Closed Loop Medicine has created a proprietary platform for the creation of drug plus digital combination products, considered the next generation of patient centric pharmaceuticals.

Closed Loop Medicine has induced a shift in the industry by creating a new standard for the future of care for people with long-term conditions. Previously, precision medicine had only been possible for a few medical conditions, but Closed Loop’s delivery of behavioural therapy with drug therapy, as a single prescription, has changed this.

Funding raised will be invested primarily into its personalised drug plus digital therapy products. Moving forward, the platform will see further development as the company accelerates the registration and commercialisation of both the platform and its precision dosing products.

Steph headshot

Steph

Company Specialist at Welcome to the Jungle

Benefits

  • 25 days holiday (plus 3 days Christmas shut down)
  • Private Medical Insurance
  • Life Assurance
  • Hybrid working

Funding (last 2 of 6 rounds)

Nov 2021

$16.8m

SERIES A

Jul 2020

$0.4m

GRANT

Total funding: $21.5m

This company has top investors

Leadership

Previously served as CEO for Northern Health Science Alliance, COO of Life Science Investment Organisation for UK Trade & Investment. Currently Non-Executive Chair for Health Innovation Research Alliance Northern Ireland.